{"BAC": {"Ticker": "BAC", "Company": "Bank of America", "Sector": "Financials", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Odeon", "Rating_Change": "Buy to Hold", "Target_Change": "$35.20"}, {"Date": "2023-02-09", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Mkt Perform to Underperform", "Target_Change": "$35 to $33"}, {"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$40"}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$36 to $33"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$38.44"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$45 to $36"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Deutsche Bank", "Keefe Bruyette", "Piper Sandler", "Atlantic Equities", "Odeon"], "Price_Target": 35.5}, "CNC": {"Ticker": "CNC", "Company": "Centene Corporation", "Sector": "Health Care", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$94 to $79"}, {"Date": "2023-02-23", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$94 to $90"}, {"Date": "2022-12-13", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$100 to $85"}], "Score": -1.67, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Deutsche Bank", "BofA Securities", "JP Morgan"], "Price_Target": 84.67}, "CMS": {"Ticker": "CMS", "Company": "CMS Energy", "Sector": "Utilities", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities"], "Price_Target": 0}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$97 to $78"}, {"Date": "2023-02-06", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Underperform", "Target_Change": "$95 to $66"}, {"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$95 to $80"}], "Score": -2.25, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Piper Sandler", "Raymond James", "Wells Fargo", "Bernstein"], "Price_Target": 74.67}, "EL": {"Ticker": "EL", "Company": "Est\u00e9e Lauder Companies", "Sector": "Consumer Staples", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Upgrade", "Organization": "Societe Generale", "Rating_Change": "Hold to Buy", "Target_Change": "$294"}, {"Date": "2023-02-17", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$295"}, {"Date": "2023-01-17", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$245 to $300"}, {"Date": "2022-12-15", "Rating": "Initiated", "Organization": "Redburn", "Rating_Change": "Sell", "Target_Change": "$210"}], "Score": 0.75, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Redburn", "Societe Generale", "Citigroup", "Oppenheimer"], "Price_Target": 274.75}, "TSLA": {"Ticker": "TSLA", "Company": "Tesla", "Sector": "Consumer Discretionary", "Updated": "2023-03-08", "Rating": [{"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$200 to $210"}, {"Date": "2023-02-15", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$275"}, {"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Berenberg", "Rating_Change": "Hold to Buy", "Target_Change": "$255 to $200"}, {"Date": "2023-01-27", "Rating": "Reiterated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$374 to $257"}, {"Date": "2023-01-23", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$299 to $245"}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Sell", "Target_Change": ""}, {"Date": "2023-01-09", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$275 to $135"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$348 to $299"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Underweight", "Target_Change": "$150 to $125"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$235 to $205"}, {"Date": "2022-12-29", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$330 to $250"}, {"Date": "2022-12-28", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$316 to $252"}, {"Date": "2022-12-23", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$250 to $175"}, {"Date": "2022-12-22", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$304 to $275"}, {"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 16, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Berenberg", "Wedbush", "BofA Securities", "Barclays", "Edward Jones", "JP Morgan", "Robert W. Baird", "Truist", "Oppenheimer", "Morgan Stanley", "Guggenheim", "Goldman", "Canaccord Genuity", "Argus"], "Price_Target": 223.31}}